Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

about

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.

P2860

Q55379857-779D057B-CA21-4D33-928D-ED0BF5423669

P2860

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

Item

http://www.wikidata.org/entity/Q47121746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@en

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@nl

type

Item

label

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@en

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@nl

prefLabel

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@en

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@nl

P1476

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

@en

P2093

Davide Sassera

http://www.w3.org/2001/XMLSchema#string

Giorgio Barbarini

http://www.w3.org/2001/XMLSchema#string

Leone De Marco

http://www.w3.org/2001/XMLSchema#string

Marta Premoli

http://www.w3.org/2001/XMLSchema#string

Paolo Sacchi

http://www.w3.org/2001/XMLSchema#string

Renato Maserati

http://www.w3.org/2001/XMLSchema#string

Roberto Gulminetti

http://www.w3.org/2001/XMLSchema#string

Stefano Novati

http://www.w3.org/2001/XMLSchema#string

P2860

Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities

Fast and accurate short read alignment with Burrows-Wheeler transform

From non-A, non-B hepatitis to hepatitis C virus cure

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

Global distribution and prevalence of hepatitis C virus genotypes.

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients.

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

P2888

s41598-017-15987-1

P304

16017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-15987-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092730365

http://www.w3.org/2001/XMLSchema#string

P698

29167469

http://www.w3.org/2001/XMLSchema#string

P932

5700050

http://www.w3.org/2001/XMLSchema#string

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

about

P2860

P2860

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932